HT
Helen Torley sold $6M of HALO stock
Helen Torley, President And CEO of Halozyme Therapeutics, Inc. (HALO), sold 60,000 shares of HALO stock worth $6M, per an SEC Form 4 filed Nov 17, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Nov 12, 2026, 5 days before it was made public.
HALO has moved -7.6% since the trade date, from $100.67 to $93.04 (Nov 19, 2026 close).
- Traded
- Nov 12, 2026
- Disclosed
- Nov 17, 2026
- Filing delay
- 5 days
- Price since
- -7.6%
- Role
- President And CEO
- Source
- SEC Form 4